phase readout
saveNCT07109297: Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India
ACTIVE_NOT_RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Sanofi. Phase: PHASE4. Conditions: RSV Immunization
view source ↗
comments(0)
5-min edit window · permanent after that